10-KPeriod: FY2021

HCA Healthcare, Inc. Annual Report, Year Ended Dec 31, 2021

Filed February 18, 2022For Securities:HCA

Summary

HCA Healthcare, Inc. (HCA) reported strong revenue growth in its 2021 10-K filing, with revenues increasing by 14.0% to $58.752 billion. This growth was driven by an increase in revenue per equivalent admission and a rise in overall patient volumes, including significant increases in outpatient surgeries and emergency room visits, indicating a recovery from pandemic-related disruptions. The company's strategic focus on growing its presence in existing markets and leveraging its scale appears to be contributing to this performance. Despite the positive revenue trend, investors should note the company's substantial leverage, with total indebtedness at $34.579 billion as of December 31, 2021. While HCA has actively managed its debt, this level of leverage remains a key consideration for risk assessment. The company also continues to navigate the evolving healthcare landscape, including regulatory changes, price transparency initiatives, and labor market challenges, all of which are potential factors influencing future operational and financial performance.

Financial Highlights

48 data points
Beta

Revenue

$58.75B

Net Income

$6.96B

11.8% Net Margin

EPS (Diluted)

$21.16

Total Assets

$50.74B

Cash & Equivalents

$1.45B

Free Cash Flow

$5.38B

Financial Statements
Beta
Revenue$58.75B
Operating Expenses$48.92B
Interest Expense$1.57B
Net Income$6.96B
EPS (Basic)$21.52
EPS (Diluted)$21.16
Shares Outstanding (Basic)323.31M
Shares Outstanding (Diluted)328.75M

Key Highlights

  • 1HCA Healthcare reported a 14.0% increase in revenues for 2021, reaching $58.752 billion, driven by improved patient volumes and revenue per admission.
  • 2The company experienced a significant rebound in patient volumes, with a 4.0% increase in consolidated admissions and a 13.8% increase in emergency room visits compared to 2020.
  • 3Outpatient surgical volumes saw a substantial 14.2% increase on a consolidated basis, highlighting a strong recovery in this segment.
  • 4Despite strong revenue growth, HCA Healthcare carries a significant debt burden, with total indebtedness reported at $34.579 billion as of December 31, 2021.
  • 5The company repurchased approximately $8.47 million shares of its common stock in the fourth quarter of 2021, demonstrating a commitment to returning capital to shareholders.
  • 6HCA Healthcare's operations are heavily concentrated in Florida and Texas, with these states accounting for 49% of consolidated revenues, making the company susceptible to specific regional economic and regulatory conditions.
  • 7The company managed its labor costs effectively, with salaries and benefits as a percentage of revenues decreasing slightly year-over-year, though facing increased costs due to contract labor and premium pay.

Frequently Asked Questions

HCA Healthcare's revenue growth in 2021 was primarily driven by a combination of a 6.8% increase in revenue per equivalent admission and a 6.8% increase in equivalent admissions, indicating both higher patient volumes and improved pricing or service mix.

As of December 31, 2021, HCA Healthcare had total indebtedness of $34.579 billion. While the company has access to significant revolving credit facilities and has been actively managing its debt, this substantial leverage exposes it to interest rate fluctuations and requires a significant portion of cash flow for debt servicing, which investors should consider.

While patient volumes improved in 2021 as pandemic-related restrictions eased, HCA Healthcare continued to be impacted by COVID-19. This included managing resurgences of cases, potential impacts on patient acuity, and increased costs related to staffing and supplies, though the company also benefited from some COVID-19 related reimbursements.

HCA Healthcare's growth strategy focuses on expanding its presence in existing markets, achieving industry-leading performance, recruiting physicians, leveraging its scale, and pursuing a disciplined development strategy through acquisitions and new facilities. The company also demonstrated a commitment to shareholder returns through share repurchases and a reinstated quarterly cash dividend.